6 Spike antibody seroconversion and emerging variant cross-reactivity following COVID-19 third vaccination dose in Australian people with multiple Sclerosis

BackgroundCOVID-19 vaccination-induced Spike antibodies are attenuated in people living with multiple sclerosis (pwMS) on high-efficacy disease-modifying therapies (DMTs). It is currently unknown whether vaccine boosters will elicit a greater protective antibody cross-reactivity against emerging var...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	BMJ neurology open 2023-08, Vol.5 (Suppl 1), p.A3-A3
Hauptverfasser:	Pillay, Aleha, Yeola, Avani, Houston, Samuel, Maltby, Vicki E, Fabis-Pedrini, Marzena, Le-Kavanagh, Linh, Merheb, Vera, Lee, Fiona XZ, Nguyen, Kristy, Walters, Susan, Taha, Marinda, O’Connell, AnnMaree, Roldan, Angie, Monif, Mastura, Butzkueven, Helmut, Jokubaitis, Vilija, Sanpangi, Sandeep, Craig, Alison, Hardy, Todd A, Barnett, Michael H, Kermode, Allan G, Dwyer, Chris, Kalincik, Tomas, Broadley, Simon, Reddel, Stephen W, Ramanathan, Sudarshini, Lechner-Scott, Jeanette, Walt, Anneke Van der, Brilot, Fabienne
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies Concurrent Session Abstracts COVID-19 vaccines Immunization Multiple sclerosis Severe acute respiratory syndrome coronavirus 2
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!